In summary, CD38 enhances the development of pristane-induced lupus by regulating the cell death of Ly6Chi monocytes and Ly6Clo monocytes/macrophages in a TRPM2-dependent and ART2-independent manner that worsens the early inflammatory response in the peritoneum. This evidence concerns the gene TRPM2 and systemic lupus erythematosus.